Back to Success Stories

CASM Technology

CASM Technology LLP was founded in 2013 by Professor David Weir and Dr Jeremy Reffin of the School of Informatics at the University of Sussex, in collaboration with members of the University’s Natural Language Processing research group, and researchers at the Demos think tank. Since then, it has evolved into a research and technology organisation that combines AI with human expertise to understand and respond to online harms such as disinformation, extremism and information manipulation, building tools and methods that help governments, civil society and other organisations spot and tackle emerging threats in complex online spaces.

CASM Technology team in their offices at Sussex Innovation

The Challenge

Sussex Innovation initially approached CASM to share a grant funding opportunity from the UK Government’s Sovereign AI programme, intended “to demonstrate proof of concept of AI technologies with state-of-the-art performance in areas of strategic importance to the UK”. Already aware of the programme, CASM invited us to collaborate on the bid, feeling that our involvement would strengthen the application.

The project would build on over a decade of expertise in analysing manipulation and disinformation in online spaces, and a technically strong proof of concept for detecting “LLM poisoning”: the deliberate manipulation of training data to distort AI outputs and decision-making.

However, that expertise had been built largely around government and civil society applications, and the team needed to understand whether, and where, the technology could create value in a much wider commercial context: which sectors and users faced the greatest risk from LLM poisoning, how ready those markets were to recognise and act on that risk, and what would need to be true for organisations to adopt and pay for a solution like CASM’s.

In light of this challenge, Sussex Innovation’s brief was a common requirement for deep tech innovators; convening external stakeholders to help CASM understand the broader commercial opportunities arising from their technology.

CASM LLM poisoning roundtable event

Our Solution

Sussex Innovation led the commercial and ecosystem-facing strand of the project, working alongside CASM’s technical research and development to build a rounded picture of the opportunity.

The work began with a detailed market-mapping exercise, assessing exposure to LLM poisoning and adversarial AI risk across five sectors identified as the leading edge of awareness and procurement: financial services, healthcare and life sciences, government and defence, technology and infrastructure providers, and professional services. The mapping also looked beyond these obvious early adopters, identifying sectors with significant but under-recognised exposure from AI that is often embedded indirectly through third-party tools, rather than deployed deliberately.

Alongside the market mapping, Sussex Innovation examined how organisations currently buy AI security and integrity solutions, surfacing barriers including fragmented ownership of AI risk within organisations, a lack of shared definitions for adversarial AI and poisoning, and the tendency for procurement to lag well behind where the risk is actually emerging.

This research formed the evidence base for a cross-sector roundtable, bringing together business leaders and experts to explore where LLM vulnerabilities are already emerging, how poisoning risks could impact organisations, and what meaningful mitigation looks like in practice. Attendees spanned a deliberately broad mix of industries, from communications and consultancy to manufacturing, engineering, data and investment, reflecting the project’s finding that LLM poisoning risk is not confined to the sectors most likely to expect it.

CASM LLM poisoning roundtable event

The Outcome

The project helped CASM move from a technically strong proposition to a much clearer understanding of who might use the technology, where the most credible applications sit, what barriers to adoption need to be addressed, and how the solution could realistically reach the market. Early on, it revealed that the opportunity lay not only in identifying LLM poisoning, but in helping organisations to perform deep analysis of how they and their products are portrayed by LLMs.

Beyond the research findings themselves, the roundtable and direct stakeholder engagement created external validation and relationships that can inform the next stage of CASM’s product development and commercialisation. The project also gave CASM’s wider Sovereign AI programme a stronger evidence base around market need, adoption, and routes to impact, complementing the technical R&D with a grounded commercial narrative. Feedback from roundtable attendees reflected the value of bringing such a diverse group into the room:

Jo Sutherland - MD Magenta Associates

“I left this session feeling invigorated and hopeful. I didn’t expect that to be the case given the subject matter – I mean, ‘LLM poisoning’ doesn’t sound particularly ‘feel good’. But the clever minds combatting it… well, they’re something else.”

Jo Sutherland – Managing Director, Magenta Associates
Mark Bullen - CEO GB Technology Group

“Enjoyed the session and the opportunity to participate with some industry insight. Good idea, CASM Technology; there will be plenty more safety barriers required as LLMs are rolled out and adopted as business normal.”

Mark Bullen – CEO, GB Technology Group
CASM LLM poisoning roundtable event

What’s Next?

CASM and Sussex Innovation are now working collaboratively to continue and deepen the research partnership, seeking out potential sources of commercial and grant funding where the LLM poisoning model could be applied. CASM is currently working with the University of Sussex student recruitment team to better understand how LLMs source information relating to the University’s reputation.

The project has demonstrated a useful model for deep tech innovators: CASM led the core technical innovation, while Sussex Innovation translated that innovation into market insight, stakeholder engagement, and an actionable commercial pathway, giving the technology a much stronger foundation from which to reach the market.

 

Prof David Weir - co-founder, CASM Technology

“Sussex Innovation’s involvement helps to bring gravitas to our grant funding applications. Their team have built a thorough understanding of our capabilities, and we still regularly meet and discuss opportunities to take the project forward.”

Prof David Weir – Co-founder, CASM Technology